Ovarian cancer researchers identify key genetic targets for chemotherapy-resistant patients

The most common type of ovarian cancer is high-grade serous ovarian carcinoma (HGSOC), which accounts for up to 70% of all ovarian cancer cases. These patients are often diagnosed at an advanced stage (III or IV) and the disease is associated with high mortality. First-line treatment for these patients is a combination of surgery to remove tumor tissue and chemotherapy.

Click here to read the full story. 

The Department of Obstetrics and Gynecology